Login

James P. Scriven, CEO of IDB Invest, focuses on Latin American finance and development in collaboration with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Critical Need for Historical Knowledge in Military Strategy
00:10:00
Knut Nesse Discusses Future of Food Production: An Exclusive Interview | Knut Nesse - Chief Executive Officer of akva group
00:10:00
Francisco Partners' DJ Deb on Tech Investment Trends and Market Risks | Dipanjan Deb, CEO, Francisco Partners.
00:10:00
Geoff Yang on AI's Rise: Transformative Trends in Technology and Investment | Geoff Yang, Co-Founder, Redpoint Ventures.
00:10:00
American West Metals Managing Director Dave O'Neill Discusses Key Developments at PDAC 2024 | Dave O'Neill, Managing Director, American West Metals Ltd.
00:10:00
Peruvian Mining Supplier Registration Procedure | Santiago Montt V. - Founder , CEO of Montt Group Inc.
00:10:00
SenesTech is committed to improving the health of the world|Joel Fruendt,Chief Executive Officer,SenesTech
00:10:00
AboitizPower President and CEO Manny Rubio reviews the company's 2023 performance and provides insights in this video.
00:10:00
CEO Suvankar Sen Reflects on Senco Gold's Milestones with GJEPC at IIJS Premiere | Mr. Suvankar Sen, CEO, Senco Gold & Diamonds.
00:10:00
Capital Markets Issuances: Insights from Daniel D. Camacho
00:10:00
Gem Group Presents Semi-Precious Stones to Guyana's Geology Commission for Market Development
00:10:00
Steve Klar on Asset Management's Role in Achieving Sustainable Development Goals: Balancing Returns and Positive Impact - A Discussion at the UN World Investment Forum by Force for Good

© 2026 Nehu